MedPath

Epoprostenol

Generic Name
Epoprostenol
Brand Names
Flolan, Veletri
Drug Type
Small Molecule
Chemical Formula
C20H32O5
CAS Number
35121-78-9
Unique Ingredient Identifier
DCR9Z582X0
Background

A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension.

Indication

For the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy.

Associated Conditions
Pulmonary Arterial Hypertension (PAH)
Associated Therapies
-

Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)

Phase 4
Completed
Conditions
Oxygenation During One Lung Ventilation
Interventions
First Posted Date
2016-04-22
Last Posted Date
2019-05-17
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
8
Registration Number
NCT02748265
Locations
🇨🇦

Toronto General Hospital, 200 Elizabeth St., Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath